Postdoctoral Research Associate
University of North Carolina at Chapel Hill
I am a postdoctoral trainee at UNC Chapel Hill supported by the UNC-Duke Collaborative Clinical Pharmacology T32 program. For my postdoctoral research in the group of Dr. David van Duin, I have investigated the factors and outcomes associated with multidrug-resistant Enterobacteriaceae in patients included in the Consortium on Resistance against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE-1 and CRACKLE-2) studies, which are two multicenter, prospective, observational cohorts of patients with CRE. I received a PhD in Microbiology and Immunology from the University of Michigan where I investigated the impact of adherence and motility of Uropathogenic Escherichia coli (UPEC) on virulence and colonization in the murine urinary tract infection model. I also received a MS in Epidemiological Sciences from the University of Michigan School of Public Health. My scientific focus is in understanding the bacterial, host, and therapeutic factors that contribute to the spread of multidrug resistant bacteria in hospital. I plan to investigate this urgent public health threat using a translational multidisciplinary approach that combines wet-lab techniques, bioinformatics, clinical epidemiology, and machine learning.
Disclosure: Nothing to disclose